China approves J&J psoriasis pill Icotyde, says drugmaker - Reuters
China approves J&J psoriasis pill Icotyde, says drugmaker Reuters
Coverage by Political Leaning
See how different sides of the spectrum reported this story
Key People
No people linked to this story
Locations
All Coverage
<a href="https://news.google.com/rss/articles/CBMiwwFBVV95cUxNbEZGMms0NUZMSnYxY1VpSUFwTXp2RzZZdFNpcmdKTmU3NklNaXF0NVlwVjl2RGF6cVBFbEx5R1dOdUgxQXRHT3BiRDM4SnBHbDFBc0RLUFA0N0xRMHpvb3ZsQUk5RHhtQ2tlTE1CWnV5aFFZNGQ1LW45NVJmOHhtakxmRzkxN1F5ZkVsMVhBc0hvY0hNZXRjbnNyODFYWFBTRHlNUGFsUTk3UjBjRWNmb2NpYU5WSU14MkpwOFFGYkZ2OVU?oc=5" target="_blank">China approves J&J psoriasis pill Icotyde, says drugmaker</a> <font color="#6f6f6f">Reuters</font>
Similar Stories
Related coverage based on topic and tags
China's drug regulator accepts Novo Nordisk's application for oral Wegovy - Reuters
China's drug regulator accepts Novo Nordisk's application for oral Wegovy Reuters
August 27, 2026 at 03:47 AMUS FDA expands approval for J&J's drug for rare blood disorder - Reuters
US FDA expands approval for J&J's drug for rare blood disorder Reuters
August 24, 2026 at 10:49 PMUS FDA approves Roivant-Priovant's skin and muscle disease drug - Reuters
US FDA approves Roivant-Priovant's skin and muscle disease drug Reuters
August 27, 2026 at 10:42 PMGSK scores regulatory wins for chronic hepatitis B drug, cancer therapy - Reuters
GSK scores regulatory wins for chronic hepatitis B drug, cancer therapy Reuters
August 24, 2026 at 07:11 AMHuawei plans for more AI pharma tie-ups, says healthcare president - Reuters
Huawei plans for more AI pharma tie-ups, says healthcare president Reuters
August 27, 2026 at 08:27 AMRevolution's lifesaving pancreatic cancer drug wins speedy FDA approval - Reuters
Revolution's lifesaving pancreatic cancer drug wins speedy FDA approval Reuters
August 26, 2026 at 06:18 PM